Ozempic
drug
Ozempic is a brand name for the medication semaglutide, produced by Novo Nordisk, used to treat type 2 diabetes. Known for its effectiveness in controlling blood sugar levels and aiding weight loss, it has become a widely prescribed injectable option in diabetes management.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
22,460
Power
743$
Sentiment
7.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 7.00 | 0.04% | +0% | 60,461,826 | 22,460 | $2,000,000 | 743$ |
| Totals | 1 | 60,461,826 | 22,460 | $2,000,000 | 743$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Ozempic is another popular injectable drug that Eli Lilly's Orforglipron is compared to.
7